US EditionRussia Has Lost Access to Modern Pharmaceutical Research
3 Articles
3 Articles
After the invasion of Ukraine, the number of clinical trials in the Russian Federation fell 20 times. This cuts off Russians from innovative drugs against HIV, oncology and other diseases.
Russia has deprived its citizens of innovative treatmentThe number of multi-center clinical trials in the Russian Federation has decreased by 20 times since 2021, cutting off Russians from innovative drugs. This applies to drugs for HIV, oncology and other diseases, as Moscow does not recognize the results of international research without local participation.
This is reported by the Foreign Intelligence Service of Ukraine.According to the report, after the start of a full-scale war against Ukraine, international pharmaceutical companies massively stopped multi-center clinical trials in Russia.The number of such studies has decreased by almost 20 times - from 376 in 2021 to only 18 in 2024. This is primarily about drugs for the treatment of cancer, HIV, hepatitis and other serious ailments, as well as…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
